Search Results

There are 38348 results for: content related to: Antiviral or proviral action of mycophenolic acid in hepatitis B infection?

  1. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 5, November 1999, Pages: 492–500, Anthony G. Johnson, Russell J. Rigby, Paul J. Taylor, Christopher E. Jones, Joan Allen, Kirsten Franzen, Michael C. Falk and David Nicol

    Version of Record online : 25 NOV 1999, DOI: 10.1016/S0009-9236(99)70012-3

  2. You have free access to this content
    Low levels of mycophenolic acid induce differentiation of human neuroblastoma cell lines

    International Journal of Cancer

    Volume 112, Issue 2, 1 November 2004, Pages: 352–354, Elisa Messina, Paola Gazzaniga, Vanna Micheli, Lucio Barile, Federico Lupi, Anna Maria Aglianò and Alessandro Giacomello

    Version of Record online : 16 JUN 2004, DOI: 10.1002/ijc.20425

  3. You have free access to this content
    A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients

    British Journal of Clinical Pharmacology

    Volume 62, Issue 4, October 2006, Pages: 477–484, Nicolas Picard, Aurélie Prémaud, Annick Rousseau, Yannick Le Meur and Pierre Marquet

    Version of Record online : 27 FEB 2006, DOI: 10.1111/j.1365-2125.2006.02509.x

  4. Comment on ‘Mycophenolic acid attenuates the tumour necrosis factor-a-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-κB and ROS pathways’ by Olejarz et al.

    European Journal of Clinical Investigation

    Volume 45, Issue 1, January 2015, Pages: 109–110, Paulo J. Oliveira

    Version of Record online : 30 DEC 2014, DOI: 10.1111/eci.12382

  5. Pharmacokinetics of Mycophenolic Acid in Patients with Lupus Nephritis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 1, January 2009, Pages: 7–16, Melanie S. Joy, Tandrea Hilliard, Yichun Hu, Susan L. Hogan, Mary Anne Dooley, Ronald J. Falk and Philip C. Smith

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.1.7

  6. You have free access to this content
    Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers

    International Journal of Cancer

    Volume 110, Issue 4, 1 July 2004, Pages: 621–625, Akihiko Okayama, Sherri Stuver, Masao Matsuoka, Junzo Ishizaki, Gen-ichi Tanaka, Yoko Kubuki, Nancy Mueller, Chung-cheng Hsieh, Nobuyoshi Tachibana and Hirohito Tsubouchi

    Version of Record online : 15 MAR 2004, DOI: 10.1002/ijc.20144

  7. Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid After Enteric-Coated Mycophenolate Versus Mycophenolate Mofetil in Patients With Progressive IgA Nephritis

    The Journal of Clinical Pharmacology

    Volume 47, Issue 7, July 2007, Pages: 850–859, Dr David Czock, Dr Franz Maximilian Rasche, Dr Alexander Carius, Dr Petra Glander, Dr Klemens Budde, Dr Steffen Bauer, Dr Frieder Keller and Dr Lutz von Mμller

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007301624

  8. Cytoplasmic rods and rings in mycophenolic acid treatment

    Liver International

    Volume 37, Issue 11, November 2017, Pages: 1742–1743, Kan Chen, Buyun Ma, Maikel P. Peppelenbosch and Qiuwei Pan

    Version of Record online : 10 AUG 2017, DOI: 10.1111/liv.13530

  9. Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatment.

    Liver International

    Volume 37, Issue 11, November 2017, Pages: 1743–1744, Jordan J. Feld, Jean-Michel Pawlotsky, Fernando Tatsch, Mark Sulkowski, Fred Poordad and Ira Jacobson

    Version of Record online : 24 OCT 2017, DOI: 10.1111/liv.13567

  10. RE: Long-term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a four-yr analysis of the Mycophenolic acid (MORE) study

    Clinical Transplantation

    Volume 28, Issue 5, May 2014, Page: 633, Keith Melancon, Afshin Parsikia and Jorge Ortiz

    Version of Record online : 13 MAR 2014, DOI: 10.1111/ctr.12327

  11. You have free access to this content
    Successful pregnancy after ABO-incompatible kidney transplantation

    Transplant International

    Volume 29, Issue 4, April 2016, Pages: 506–507, Laure Esposito, Lionel Rostaing and Nassim Kamar

    Version of Record online : 29 DEC 2015, DOI: 10.1111/tri.12724

  12. You have free access to this content
    Commentary on: Jiang B, Zhu F, Cao L, Presley BR, Shen MS, Yang KH. Computational study of fracture characteristics in infant skulls using a simplified finite element model. J Forensic Sci 2017;62(1):39–49

    Journal of Forensic Sciences

    Volume 63, Issue 1, January 2018, Pages: 345–348, L. Dutch Johnson and Roland Auer

    Version of Record online : 5 JAN 2018, DOI: 10.1111/1556-4029.13706

  13. You have free access to this content
    Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

    British Journal of Clinical Pharmacology

    Volume 59, Issue 3, March 2005, Pages: 271–280, Bronwyn A. Atcheson, Paul J. Taylor, David W. Mudge, David W. Johnson, Carmel M. Hawley, Scott B. Campbell, Nicole M. Isbel, Peter I. Pillans and Susan E. Tett

    Version of Record online : 22 DEC 2004, DOI: 10.1111/j.1365-2125.2004.02235.x

  14. The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function

    Clinical Pharmacology & Therapeutics

    Volume 63, Issue 5, May 1998, Pages: 512–518, Heather J. Johnson, Suzanne K. Swan, Karen L. Heim-Duthoy, Andrew J. Nicholls, Irene Tsina and Thomas Tarnowski

    Version of Record online : 22 MAY 1998, DOI: 10.1016/S0009-9236(98)90102-3

  15. Interdisciplinary Collaborative Team for Blastocyst Implantation Research: inception and perspectives

    American Journal of Reproductive Immunology

    Volume 71, Issue 1, January 2014, Pages: 1–11, Koji Yoshinaga, Mercy PrabhuDas, Christopher Davies, Kenneth White, Kathleen Caron, Thaddeus Golos, Asgerally Fazleabas, Bibhash Paria, Gil Mor, Soumen Paul, Xiaoqin Ye, Sudhansu K. Dey, Thomas Spencer and Robert Michael Roberts

    Version of Record online : 29 NOV 2013, DOI: 10.1111/aji.12173

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 71, Issue 5, 485, Version of Record online: 16 APR 2014

  16. Mycophenolate Mofetil in Islet Cell Transplant: Variable Pharmacokinetics but Good Correlation Between Total and Unbound Concentrations

    The Journal of Clinical Pharmacology

    Volume 45, Issue 8, August 2005, Pages: 901–909, Pamala A. Jacobson, Kathleen G. Green and Bernhard J. Hering

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005278599

  17. Catalytic oxidation of alkanethiols and dialkyldisulfides to alkanesulfonic acids by H2O2/CH3ReO3 examined by electrospray ionization mass spectrometry

    Journal of Mass Spectrometry

    Volume 49, Issue 3, March 2014, Pages: 241–247, Austin B. Murphy, Chi N. Duong, Karmalita K. Crenshaw, Savannah K. Hartman, William F. Barrett IV, Alyssa R. Whitehead, Andrew J. Lampkins and Brian W. Gregory

    Version of Record online : 25 FEB 2014, DOI: 10.1002/jms.3325

  18. Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2059–2066, Louisa Clare Johnston, Michael John Jackson, Sarah Rose, Andrew Christopher McCreary and Peter Jenner

    Version of Record online : 18 AUG 2010, DOI: 10.1002/mds.23249

  19. From bed to bench: 7th Joint meeting of European Tissue Repair Society (ETRS) with the Wound Healing Society (WHS) and the 25th Annual Meeting of ETRS in Copenhagen, Denmark

    Wound Repair and Regeneration

    Volume 25, Issue 2, March/April 2017, Pages: 341–346, Magnus S. Ågren, Patricia L. Danielsen, Finn Gottrup, Dimitris Kletsas, Sabine A. Eming, Susan Volk and Lisa Gould

    Version of Record online : 24 APR 2017, DOI: 10.1111/wrr.12534

  20. Empirical or unconscious reduction of the secondary immunosuppressive drug concomitantly with intended calcineurin inhibitor reduced exposure to improve kidney graft function can be followed by antibody mediated rejections

    Clinical Transplantation

    Volume 29, Issue 4, April 2015, Pages: 277–278, Fernando Gonzalez

    Version of Record online : 27 FEB 2015, DOI: 10.1111/ctr.12512